In addition, STAT3—a critical YAP/TAZ activator in tumor endothelium—represents an attractive dual-purpose target as its inhibition may impair both angiogenesis and immunosuppressive YAP/TAZ signaling88. This evidence concerns the gene YAP1 and neoplasm.